ACA

NEUTRALM&A

Arcosa, Inc.

2026-09-11

Price

$145.00

-0.17%

This is the 2026-09-11 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score5.0Watchlist

Signals6/8 DNA1/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.2xvs 20d avg

Analysis

Arcosa's (ACA) current price action is fundamentally anchored by its pending $150 per share all-cash acquisition by CRH, which officially secured stockholder approval on September 4. The stock's ultra-low 2.8% realized volatility and compressed technical signals (Quiet Storm, Bollinger Squeeze) represent textbook M&A arbitrage behavior as the market waits for final regulatory clearance. Furthermore, the RISK_ON macro regime and tightening High Yield credit spreads (OAS at 0.80%) signal a frictionless financing environment, heavily de-risking the remaining hurdles and supporting high-conviction institutional absorption of the remaining $5 deal spread.

Fired Signals

ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEMARKET LEADERPERFECT STACKBARGAIN HUNTERDISTRIBUTION

Key Takeaways

Stockholder approval on September 4 cements the $150/share all-cash buyout by CRH, shifting all focus to regulatory clearance.
Technical compression signals and minimal 2.8% volatility reflect a classic M&A arbitrage holding pattern rather than organic price discovery.
A resilient RISK_ON macro backdrop with unbothered credit markets heavily minimizes systemic deal-break or financing risks.

← Back to 2026-09-11 View Full ACA History →Yahoo Finance &nearr;